From Breakthroughs Blog: Product Development Partnerships

 
UN Photo/Loey Felipe
Overheard at UNGA: 4 key takeaways on global health innovation

A “who’s who” of politicians, philanthropists, CEOs, and civil society leaders descended upon New York City this week for the annual United Nations General Assembly (UNGA). GHTC was there, serving as your eyes and ears on the ground. Here is what we heard and our top four takeaways on global health R&D.

Read More
Neil Palmer/CIAT
Preparing the ground in the Brazilian Amazon for a new antimalarial to reduce relapse

Tackling malaria in the Brazilian Amazon has proved challenging. But furtunetly, a solution could be in sight.

Read More
Sanofi Pasteur / Patrick Boulen
A year in review: The global health innovation stories that shaped 2017

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news in 2017.

Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Read More
PATH/Jared Wilmoth
​G20: Connecting the dots on global health innovation, sustainable development, and health security

On April 28, senior leaders from government, the private sector, and the global health community came together in Berlin for a lively discuss on how the G20 can advance global health innovation to drive sustainable development and health security.

Read More
PATH/Gabe Bienczycki
Opening up malaria drug discovery for good

Scientists are exploring new open innovation and open source approaches to catalyze malaria drug development and move us closer to achieving the goal of ending malaria for good.

Read More
PATH/Dunia Faulx
A year in review: The top stories in global health innovation that shaped 2016

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news 2016. 

GHTC
Read More
International Partnership for Microbicides
Research Roundup: The HIV/AIDS and STIs edition

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases (NIAID)
Research Roundup: TB drug development, mosquitoes’ secret weapon, and a new platform for antibiotic R&D

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Glenn Austin
Research Roundup: New insights into Zika virus, using silk to preserve blood samples, and a single dose oral cholera vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Lesley Reed
Incentives and innovative financing mechanisms matter in addressing market failures

When existing market forces alone fall short in ensuring availability of and access to lifesaving health tools, a range of interventions are needed to alter the market and ultimately change the behavior of its actors.

GHTC
Read More
GHTC/Marissa Chmiola
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

GHTC
Read More
Research Roundup: Vaccines for Rift Valley Fever, MERS, and Zika

A vaccine candidate against Rift Valley Fever appears to be safe and effective for livestock and has the potential for use in humans.

GHTC
Read More
365 review: Top global health innovation news of 2015

As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.

GHTC
Read More
Research Roundup: flesh-eating bacteria treatment, Hepatitis C in Egypt, and access to compounds for drug discovery

Global Health Now took an in-depth look at the flesh-eating fungus mycetoma—which enters the body through cuts, and can result in swollen, deformed limbs—in a three-part series on this Untold Global Health Story of 2015.

GHTC
Read More
Research Roundup: kid-friendly malaria medicine, Zika fever, priority review vouchers, and more

After four successful Phase 3 clinical trials enrolling more than 3,500 patients in 18 countries, the European Medicines Agency (EMA) has granted Pyramax® Granules, a pediatric malaria medicine, a positive opinion under Article 58—a mechanism through which the EMA reviews and issues a scientific opinion on products that are not intended for use in Europe.

GHTC
Read More
GHTC
GHTC briefing highlights importance of health innovation to achieving global goals

With the Sustainable Development Goals (SDGs) freshly adopted, the Global Health Technologies Coalition (GHTC) gathered representatives from the private, public, and nonprofit sectors on Capitol Hill this past Wednesday to discuss what it will take to achieve the global goals.

Read More
When breastfeeding is not possible: How an innovative cup can save lives

Breast milk is the perfect first food for newborns; it provides nutrients and energy that infants need and contains substances that strengthen their immune systems.

Read More
Passing the ball: DNDi transfers malaria therapies to MMV

The Drugs for Neglected Disease initiative (DNDi) and the Medicines for Malaria Venture (MMV)—nonprofit product development partnerships (PDPs) and members of the Global Health Technologies Coalition—have teamed up to ensure two treatments for malaria continue to reach the patients who need them most.

GHTC
Read More
PATH/Doune Porter
Four reasons to visit the Contraceptive Technology Innovation Exchange today

Over the past several decades, overall investment in contraceptive R&D has declined dramatically. The result? Renewed commitment and partnerships will be required to ensure that new contraceptive methods advance through the development pipeline and that access to the final products is affordable and equitable.

FHI360
Read More
Research Roundup: a new contraceptive option, China’s role in global health R&D, and vaccines for MERS and pneumonia

Last week, GHTC member PATH launched the Caya® contoured diaphragm in the United States, after developing and testing nearly 200 prototypes to ensure the product was safe, effective, and user friendly.

GHTC
Read More
Research Roundup: cross-sector partnerships to advance drug discovery, global recommendations for contraceptive use, and a diagnostic that detects lifetime viral exposure

The Drugs for Neglected Diseases initiative (DNDi)—a member of the GHTC—is partnering with pharmaceutical companies Eisai Co., Shionogi & Co., Takeda Pharmaceutical, and AstraZeneca to accelerate early-stage research for drugs against Chagas and leishmaniasis.

GHTC
Read More
PATH/Lesley Reed
Research Roundup: Leadership shifts at USAID, new discoveries in tuberculosis research, an emerging model for nonprofit pharmaceutical companies, and more

The US Agency for International Development (USAID) announced last week that Ariel Pabos-Mendez, the assistant administrator for Global Health, will serve as the coordinator for Child and Maternal Survival.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: A new drug for tuberculosis, contraceptive research and development, drug-resistant malaria, and more

The TB Alliance, a member of the Global Health Technologies Coalition, announced last week that it will be starting Phase 1 clinical trials for a new tuberculosis (TB) drug candidate.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: Intellectual property awards, FDA priorities, Australia R&D, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
Research Roundup: UNGA, public-private partnerships, new executive orders, neglected disease R&D grants, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: New TB drugs, the Global Development Lab, licensing agreements, emergency Ebola research, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Research Roundup: New malaria drugs, chikungunya vaccines, Africa Leaders Summit, preterm births coalition, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A new era for malaria treatment

In this post, PATH Vice President of Product Development, David Kaslow, writes about the first-ever shipment of semisynthetic artemisinin (ssART)—a new type of malaria treatment that marks a significant milestone in the fight against malaria.

Read More
PATH/Eric Becker
Research Roundup: New drugs against diarrhea, the End Neglected Tropical Diseases Act, genetically-modified mosquitoes, and mines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
EDCTP2: What it means for European support for global health R&D

In this guest post, Renate Baehr—executive director of Deutsche Stiftung Weltbevoelkerung—writes about the next rendition of the European & Developing Countries Clinical Trials Partnership (EDCTP) and how its expansion will impact more lives in low- and middle-income countries.

Read More
Perspectives from nonprofits on accelerating product development and improving access for low- and middle-income countries

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a series of papers she developed for the GHTC that outlines key challenges, lessons, and potential solutions in advancing research and development (R&D) to address poverty-related and neglected diseases and conditions.

PATH
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PAHO
Celebrating 20 years of public health advancements: Sabin Vaccine Institute’s Scientific Symposium

In a fitting way to kick off World Immunization Week, several hundred people gathered Friday, April 25th to celebrate significant achievements in vaccinology over the past two decades and to examine solutions for overcoming remaining hurdles at the Sabin Vaccine Institute’s 20th Anniversary Scientific Symposium.

Sabin Vaccine Institute
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
When surviving the disease means surviving the cure

In this guest post, Dr. Mel Spigelman—president and CEO of the TB Alliance—writes about advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase III clinical

TB Alliance
Read More
GHTC
GHTC briefing highlights role of US leadership in global health R&D

“I deeply believe in the importance, power, and influence of research,” said Senator Chris Coons (D-DE) at GHTC’s congressional briefing.

GHTC
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Big news that could help fight a tiny foe

Most of us know what it’s like to be bitten by a mosquito.

GHTC
Read More
Public-private partnerships: Where have we been and where do we go?

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a series of dialogues PATH and other partners convened to discuss public-private partnerships for global health product development.

PATH
Read More
Innovation. Transformation. Inspiration. Part 1

This post was originally featured on path.org on January 27, 2013 and was written by PATH’s Drug Development program.

GHTC
Read More
Investing in R&D for neglected diseases: Three investment patterns that put lives at risk

In this guest post, Dr. Mary Moran—executive director—and Dr. Penny Farrell—analyst—from Policy Cures shares key findings from the recently released G-FINDER survey.

Policy Cures
Policy Cures
Read More
Improving the affordability, availability, and acceptability of health technologies for low- and middle-income countries

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key issues surrounding access to global health products.

PATH
Read More
GHTC
For 2015, the call for innovation is loud and clear

“We cannot solve what we need to solve with existing interventions—we need science and technology,” said Gary Cohen, executive vice president at Becton, Dickinson and Company (BD), at an official side event at the 6th Session of the Opening Working Group on Sustainable Development Goals this week in New York City.

GHTC
Read More
No more business as usual: USAID’s important role in global health R&D highlighted at Capitol Hill briefing

“You’re in a position to make such a difference and to be innovative with your thinking,” Margaret McCluskey, senior technical advisor at the US Agency for International Development (USAID), said to an audience of Congressional staffers at a briefing yesterday on Capitol Hill.

GHTC
Read More
New paper examines research funding for diseases and conditions of poverty

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key funding challenges and opportunities for global health research and development (R&D).

PATH
Read More
More good news for global health R&D as the UK ramps up its investment in product development

Close on the heels of the announcement that Australia is newly investing in global health product development, the United Kingdom last week also revealed that it’s bumping up its longstanding support in this area.

GHTC
Read More
Australia’s evolving role in global health R&D

In a notable move for global health research efforts, Australia this week announced funding for four groups developing new drugs, vaccines, and diagnostics for malaria and tuberculosis (TB).

GHTC
Read More
New paper offers insights into key challenges facing R&D for diseases of poverty

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key challenges and solutions facing research and development (R&D) for diseases of poverty.

PATH
Read More
PATH/Eric Becker
Creating partnerships for innovative, high-impact global health products

For more than 30 years, PATH has been working to advance innovative global health solutions. Partnering is a core part of PATH’s strategy and is fundamental to how we develop and deliver high-impact, cost-effective technologies.

PATH
Read More
Panel stresses partnerships and long-term support for successful global health research

“I can’t think of a reason why academic scientists should not engage in global health research,” Dr. Dennis Kyle, distinguished university health professor at the University of South Florida, said last week at the Consortium of Universities for Global Health (CUGH) annual conference.

GHTC
Read More